Published in Cancer Chemother Pharmacol on January 01, 1982
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol (1993) 2.20
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci (2000) 1.83
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia (2011) 1.70
Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.69
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia (2012) 1.60
Long term results (15-30 years) of surgical repair of aortic coarctation. Br Heart J (1987) 1.60
Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines. Eur J Cancer (1999) 1.50
Oral allergy syndrome to grapes. Allergy (1998) 1.45
UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen. Oncology (2008) 1.43
Interaction between infrared radiation and vitreous substitutes. Arch Ophthalmol (1997) 1.42
Neuropathies associated with monoclonal gammapathies. Haematologica (1995) 1.40
Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability. J Struct Biol (2000) 1.31
Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene (2007) 1.28
Changing clinical presentation of multiple myeloma. Eur J Cancer (1991) 1.24
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem (2001) 1.19
Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17
Serum albumin in Hodgkin's disease. Cancer (1985) 1.17
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol (1999) 1.07
Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy (2006) 1.06
Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.02
Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol (1986) 1.01
Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med (1995) 1.00
Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk Res (1990) 0.99
Mucoceles in the paranasal sinuses involving the orbit: CT signs in 43 cases. Neuroradiology (1982) 0.99
Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis. Br J Haematol (1996) 0.98
Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol (2001) 0.98
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia (2005) 0.98
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol (2009) 0.98
Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology. Clin Exp Rheumatol (2006) 0.97
Correlation of cell kinetic findings with morphology of non-Hodgkin's malignant lymphomas. J Natl Cancer Inst (1977) 0.96
Dot immunobinding assay as a new diagnostic test for human hydatid disease. Immunol Lett (1996) 0.96
Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol (1990) 0.95
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. Br J Haematol (2001) 0.95
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils. Eur J Biochem (1997) 0.95
Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer (1983) 0.95
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol (1990) 0.95
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood (1994) 0.95
Adult acute non-lymphoblastic leukaemia: reliability and prognostic significance of pretreatment bone marrow S-phase size determined by flow cytofluorometry. Scand J Haematol (1986) 0.94
An IgM monoclonal protein with multiple serological specificities. Clin Exp Immunol (1979) 0.93
A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood (1980) 0.92
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. Am J Hematol (1994) 0.92
New drug therapy of amyloidoses: resorption of AL-type deposits with 4'-iodo-4'-deoxydoxorubicin. Blood (1995) 0.92
An SVM classifier to separate false signals from microcalcifications in digital mammograms. Phys Med Biol (2001) 0.92
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants. Br J Haematol (1989) 0.91
Experiential cognitive therapy in the treatment of panic disorders with agoraphobia: a controlled study. Cyberpsychol Behav (2003) 0.91
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? Rheumatology (Oxford) (2005) 0.91
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects. QJM (2011) 0.90
Pelvic endometriosis: reproductive and menstrual risk factors at different stages in Lombardy, northern Italy. J Epidemiol Community Health (1995) 0.90
In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections. Histochem J (1988) 0.90
Allergic reactions to honey and royal jelly and their relationship with sensitization to compositae. Allergol Immunopathol (Madr) (1999) 0.90
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin. Eur J Cancer (2001) 0.90
Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients. Am J Transplant (2009) 0.90
A prognostic index for multiple myeloma. Br J Cancer (1996) 0.90
Diagnostic approach to and follow-up of difficult cases of AL amyloidosis. Haematologica (1996) 0.89
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci (2001) 0.89
Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis. Eur J Nucl Med (1998) 0.89
The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients. Haematologica (1999) 0.89
Severe and complicated Falciparum malaria in Italian travelers. J Travel Med (1998) 0.88
Milk-of-calcium in breast microcysts with adjacent malignancy. AJR Am J Roentgenol (1999) 0.88
Current concepts on the pathogenesis of systemic amyloidosis. Nephrol Dial Transplant (1996) 0.88
Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes. Cancer (1983) 0.88
Estimation of ferrokinetic parameters by a mathematical model in patients with primary acquired sideroblastic anaemia. Br J Haematol (1978) 0.87
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. Am Heart J (1995) 0.87
Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in a hematological/oncological outpatient section. Haematologica (1989) 0.87
Clotting alterations in primary systemic amyloidosis. Haematologica (2000) 0.87
Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias. Basic Appl Histochem (1986) 0.87
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study. Am J Transplant (2013) 0.87
Growth, growth hormone and cognitive functions. Horm Res (1996) 0.86
Low diversity in the major histocompatibility complex class II DRB1 gene of the Spanish ibex, Capra pyrenaica. Heredity (Edinb) (2004) 0.86
Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications. Biochim Biophys Acta (1996) 0.86
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. Leukemia (2005) 0.86
Oral hyposensitization to nickel induces clinical improvement and a decrease in TH1 and TH2 cytokines in patients with systemic nickel allergy syndrome. Int J Immunopathol Pharmacol (2010) 0.85
Training with computer-supported motor imagery in post-stroke rehabilitation. Cyberpsychol Behav (2004) 0.85
The diflunisal trial: update on study drug tolerance and disease progression. Amyloid (2011) 0.85
Evidence that amyloidogenic light chains undergo antigen-driven selection. Blood (1998) 0.85
Occurrence of monoclonal components in general practice: clinical implications. Eur J Haematol (1992) 0.85
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma. Cancer Chemother Pharmacol (2015) 0.84
Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Mycoses (1997) 0.84
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL). Haematologica (1999) 0.84
New clinical criteria for the assessment of liver involvement in Hodgkin's disease. Eur J Cancer Clin Oncol (1982) 0.84
Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells. Leuk Res (1991) 0.84
Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies. Acta Haematol (1991) 0.84
Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis. Am J Pathol (2001) 0.84
Biological features of the clone involved in primary amyloidosis (AL). Leukemia (2001) 0.84
Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Allergy (2002) 0.84
The putative role of alpha-1-antitrypsin in the disaggregation of amyloid lambda fibrils. J Intern Med (1995) 0.83
Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension? Heart (2002) 0.83
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. Biochim Biophys Acta (1991) 0.83
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial. Ann Oncol (2002) 0.83
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Haematologica (1998) 0.83
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. Haematologica (2000) 0.83
Immunocytochemical evaluation of proliferative activity in human brain tumours. Anal Cell Pathol (1990) 0.83
Multiple myeloma and related plasma cell dyscrasias. JAMA (1987) 0.83